Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Int J Mol Sci. 2021 Aug 16;22(16):8768. doi: 10.3390/ijms22168768.
Otolaryngology (also known as ear, nose, and throat (ENT)) diseases can be significantly affected by the level of sex hormones, which indicates that sex differences affect the manifestation, pathophysiology, and outcomes of these diseases. Recently, increasing evidence has suggested that proinflammatory responses in ENT diseases are linked to the level of sex hormones. The sex hormone receptors are present on a wide variety of immune cells; therefore, it is evident that they play crucial roles in regulating the immune system and hence affect the disease progression of ENT diseases. In this review, we focus on how sex hormones, particularly estrogens, regulate ENT diseases, such as chronic rhinosinusitis, vocal fold polyps, thyroid cancer, Sjögren's syndrome, and head and neck cancers, from the perspectives of inflammatory responses and specialized proresolving mediator-driven resolution. This paper aims to clarify why considering sex differences in the field of basic and medical research on otolaryngology is a key component to successful therapy for both males and females in the future.
耳鼻喉科学(也称为耳、鼻、喉(ENT))疾病会受到性激素水平的显著影响,这表明性别差异会影响这些疾病的表现、病理生理学和结果。最近,越来越多的证据表明,ENT 疾病中的促炎反应与性激素水平有关。性激素受体存在于多种免疫细胞上;因此,它们在调节免疫系统方面起着至关重要的作用,从而影响 ENT 疾病的疾病进展。在这篇综述中,我们从炎症反应和专门的促解决介质驱动的解决的角度,重点关注性激素(特别是雌激素)如何调节 ENT 疾病,如慢性鼻鼻窦炎、声带息肉、甲状腺癌、干燥综合征和头颈部癌症。本文旨在阐明为什么在耳鼻喉科学的基础和医学研究领域考虑性别差异是未来男性和女性成功治疗的关键组成部分。